Role of sulfatide in normal and pathological cells and tissues

Journal of Lipid Research

Volumn 53, Issue 8, 2012, Pages 1437-1450

  Takahashi, Tadanobu ^a   Suzuki, Takashi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Bacterial infection; Biological function; Diabetes; Glycolipid; Hemostasis; Immune system; Nervous system; Sulfatide; Thrombosis; Viral infection

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INSULIN; L SELECTIN; MONOCLONAL ANTIBODY; OSELTAMIVIR; SULFATIDE; SULFATIDE ANTIBODY; UNCLASSIFIED DRUG; ZANAMIVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; BACTERIAL INFECTION; BRAIN METABOLISM; CANCER GROWTH; CELLULAR IMMUNITY; CYTOLOGY; DIFFUSE LEWY BODY DISEASE; DISEASES; DRUG MECHANISM; DRUG SYNTHESIS; HELPER CELL; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOPATHOLOGY; INFECTION PREVENTION; INFLUENZA; INFLUENZA A; INFLUENZA VIRUS A; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; KIDNEY DISEASE; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; MALIGNANT NEOPLASTIC DISEASE; MICROBIAL ACTIVITY; NATURAL KILLER CELL; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARKINSON DISEASE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; REVIEW; T LYMPHOCYTE; THROMBOSIS; VACCINIA VIRUS; VIRUS REPLICATION;

ANIMALS; BACTERIAL INFECTIONS; CELL LINE; CELLS; HUMANS; ORGAN SPECIFICITY; SULFOGLYCOSPHINGOLIPIDS; VIRUS DISEASES; VIRUS REPLICATION;

EID: 84863794717     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R026682     Document Type: Review

References (161)

1. Eckhardt, M. 2008. The role and metabolism of sulfatide in the nervous system. Mol. Neurobiol. 37: 93-103.
2. Bosio, A., E. Binczek, M. M. Le Beau, A. A. Fernald, and W. Stoffel. 1996. The human gene CGT encoding the UDP-galactose ceramide galactosyl transferase (cerebroside synthase): cloning, characterization, and assignment to human chromosome 4, band q26. Genomics. 34: 69-75. (Pubitemid 26159882)
3. Honke, K., M. Tsuda, Y. Hirahara, A. Ishii, A. Makita, and Y. Wada. 1997. Molecular cloning and expression of cDNA encoding human 3′- phosphoadenylylsulfate: galactosylceramide 3′- sulfotransferase. J. Biol. Chem. 272: 4864-4868. (Pubitemid 27090034)
4. Hirahara, Y., M. Tsuda, Y. Wada, and K. Honke. 2000. cDNA cloning, genomic cloning, and tissue-specific regulation of mouse cerebroside sulfotransferase. Eur. J. Biochem. 267: 1909-1917.
5. Yaghootfam, A., T. Sorkalla, H. Häberlein, V. Gieselmann, J. Kappler, and M. Eckhardt. 2007. Cerebroside sulfotransferase forms homodimers in living cells. Biochemistry. 46: 9260-9269. (Pubitemid 47255040)
6. Kyogashima, M., K. Tamiya-Koizumi, T. Ehara, G. Li, R. Hu, A. Hara, T. Aoyama, and R. Kannagi. 2006. Rapid demonstration of diversity of sulfatide molecular species from biological materials by MALDI-TOF MS. Glycobiology. 16: 719-728. (Pubitemid 44288237)
7. Liu, Y., Y. Chen, A. Momin, R. Shaner, E. Wang, N. J. Bowen, L. V. Matyunina, L. D. Walker, J. F. McDonald, M. C. Sullards, et al. 2010. Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry. Mol. Cancer. 9: 186.
8. Honke, K., Y. Hirahara, J. Dupree, K. Suzuki, B. Popko, K. Fukushima, J. Fukushima, T. Nagasawa, N. Yoshida, Y. Wada, et al. 2002. Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc. Natl. Acad. Sci. USA. 99: 4227-4232. (Pubitemid 34285968)
9. He, H., C. A. Conrad, C. L. Nilsson, Y. Ji, T. M. Schaub, A. G. Marshall, and M. R. Emmett. 2007. Method for lipidomic analysis: p53 expression modulation of sulfatide, ganglioside, and phospholipid composition of U87 MG glioblastoma cells. Anal. Chem. 79: 8423-8430. (Pubitemid 350171348)
10. Kolter, T., and K. Sandhoff. 2005. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu. Rev. Cell Dev. Biol. 21: 81-103. (Pubitemid 41740628)
11. Zeng, Y., H. Cheng, X. Jiang, and X. Han. 2008. Endosomes and lysosomes play distinct roles in sulfatide-induced neuroblastoma apoptosis: potential mechanisms contributing to abnormal sulfatide metabolism in related neuronal diseases. Biochem. J. 410: 81-92. (Pubitemid 351300327)
12. Burkart, T., L. Caimi, H. P. Siegrist, N. N. Herschkowitz, and U. N. Wiesmann. 1982. Vesicular transport of sulfatide in the myelinating mouse brain. Functional association with lysosomes? J. Biol. Chem. 257: 3151-3156. (Pubitemid 12118092)
13. Yoda, Y., S. Gasa, A. Makita, Y. Fujioka, Y. Kikuchi, and M. Hashimoto. 1979. Glycolipids in human lung carcinoma of histologically different types. J. Natl. Cancer Inst. 63: 1153-1160. (Pubitemid 10159213)
14. Hattori, H., K. Uemura, and T. Taketomi. 1981. The presence of blood group A-active glycolipids in cancer tissues from blood group O patients. Biochim. Biophys. Acta. 666: 361-369. (Pubitemid 12144868)
15. Kobayashi, T., K. Honke, K. Kamio, N. Sakakibara, S. Gasa, N. Miyao, T. Tsukamoto, I. Ishizuka, T. Miyazaki, and A. Makita. 1993. Sulfolipids and glycolipid sulfotransferase activities in human renal cell carcinoma cells. Br. J. Cancer. 67: 76-80. (Pubitemid 23034926)
16. Kobayashi, T., K. Honke, S. Gasa, M. Sugiura, T. Miyazaki, I. Ishizuka, and A. Makita. 1993. Involvement of protein kinase C in the regulation of glycolipid sulfotransferase activity levels in renal cell carcinoma cells. Cancer Res. 53: 2484-2489. (Pubitemid 23168010)
17. Kobayashi, T., K. Honke, S. Gasa, S. Imai, J. Tanaka, T. Miyazaki, and A. Makita. 1993. Regulation of activity levels of glycolipid sulfotransferases by transforming growth factor alpha in renal cell carcinoma cells. Cancer Res. 53: 5638-5642. (Pubitemid 23360264)
18. Sakakibara, N., S. Gasa, K. Kamio, A. Makita, and T. Koyanagi. 1989. Association of elevated sulfatides and sulfotransferase activities with human renal cell carcinoma. Cancer Res. 49: 335-339. (Pubitemid 19049523)
19. Morichika, H., Y. Hamanaka, T. Tai, and I. Ishizuka. 1996. Sulfatides as a predictive factor of lymph node metastasis in patients with colorectal adenocarcinoma. Cancer. 78: 43-47. (Pubitemid 26189903)
20. Makhlouf, A. M., M. M. Fathalla, M. A. Zakhary, and M. H. Makarem. 2004. Sulfatides in ovarian tumors: clinicopathological correlates. Int. J. Gynecol. Cancer. 14: 89-93. (Pubitemid 38280628)
21. Sevin, C., P. Aubourg, and N. Cartier. 2007. Enzyme, cell and gene-based therapies for metachromatic leukodystrophy. J. Inherit. Metab. Dis. 30: 175-183. (Pubitemid 46487998)
22. Rafi, M. A., S. Amini, X. L. Zhang, and D. A. Wenger. 1992. Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-1 deficiency. Am. J. Hum. Genet. 50: 1252-1258.
23. Ishizuka, I. 1997. Chemistry and functional distribution of sulfoglycolipids. Prog. Lipid Res. 36: 245-319. (Pubitemid 28132555)
24. Hirahara, Y., R. Bansal, K. Honke, K. Ikenaka, and Y. Wada. 2004. Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice. Glia. 45: 269-277. (Pubitemid 38222255)
25. Shroff, S. M., A. D. Pomicter, W. N. Chow, M. A. Fox, R. J. Colello, S. C. Henderson, and J. L. Dupree. 2009. Adult CST-null mice maintain an increased number of oligodendrocytes. J. Neurosci. Res. 87: 3403-3414.
26. Yuki, D., Y. Sugiura, N. Zaima, H. Akatsu, Y. Hashizume, T. Yamamoto, M. Fujiwara, K. Sugiyama, and M. Setou. 2011. Hydroxylated and non-hydroxylated sulfatide are distinctly distributed in the human cerebral cortex. Neuroscience. 193: 44-53.
27. Pesheva, P., S. Gloor, M. Schachner, and R. Probstmeier. 1997. Tenascin-R is an intrinsic autocrine factor for oligodendrocyte differentiation and promotes cell adhesion by a sulfatide-mediated mechanism. J. Neurosci. 17: 4642-4651. (Pubitemid 27246922)
28. Roberts, D. D., C. N. Rao, J. L. Magnani, S. L. Spitalnik, L. A. Liotta, and V. Ginsburg. 1985. Laminin binds specifically to sulfated glycolipids. Proc. Natl. Acad. Sci. USA. 82: 1306-1310. (Pubitemid 15111042)
29. Li, S., P. Liquari, K. K. McKee, D. Harrison, R. Patel, S. Lee, and P. D. Yurchenco. 2005. Laminin-sulfatide binding initiates basement membrane assembly and enables receptor signaling in Schwann cells and fibroblasts. J. Cell Biol. 169: 179-189. (Pubitemid 40562924)
30. Ishibashi, T., J. L. Dupree, K. Ikenaka, Y. Hirahara, K. Honke, E. Peles, B. Popko, K. Suzuki, H. Nishino, and H. Baba. 2002. A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. J. Neurosci. 22: 6507-6514. (Pubitemid 35386407)
31. Honke, K., Y. Zhang, X. Cheng, N. Kotani, and N. Taniguchi. 2004. Biological roles of sulfoglycolipids and pathophysiology of their deficiency. Glycoconj. J. 21: 59-62. (Pubitemid 39360742)
32. Winzeler, A. M., W. J. Mandemakers, M. Z. Sun, M. Stafford, C. T. Phillips, and B. A. Barres. 2011. The lipid sulfatide is a novel myelin-associated inhibitor of CNS axon outgrowth. J. Neurosci. 31: 6481-6492.
33. Frank, M., M. E. van der Haar, N. Schaeren-Wiemers, and M. E. Schwab. 1998. rMAL is a glycosphingolipid-associated protein of myelin and apical membranes of epithelial cells in kidney and stomach. J. Neurosci. 18: 4901-4913. (Pubitemid 28285399)
34. Kim, T., K. Fiedler, D. L. Madison, W. H. Krueger, and S. E. Pfeiffer. 1995. Cloning and characterization of MVP17: a developmentally regulated myelin protein in oligodendrocytes. J. Neurosci. Res. 42: 413-422.
35. Coetzee, T., K. Suzuki, and B. Popko. 1998. New perspectives on the function of myelin galactolipids. Trends Neurosci. 21: 126-130. (Pubitemid 28080675)
36. Marcus, J., S. Honigbaum, S. Shroff, K. Honke, J. Rosenbluth, and J. L. Dupree. 2006. Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia. 53: 372-381.
37. Berntson, Z., E. Hansson, L. Rönnbäck, and P. Fredman. 1998. Intracellular sulfatide expression in a subpopulation of astrocytes in primary cultures. J. Neurosci. Res. 52: 559-568. (Pubitemid 28252737)
38. Pernber, Z., M. Molander-Melin, C. H. Berthold, E. Hansson, and P. Fredman. 2002. Expression of the myelin and oligodendrocyte progenitor marker sulfatide in neurons and astrocytes of adult rat brain. J. Neurosci. Res. 69: 86-93. (Pubitemid 34734168)
39. Han, X., H. Cheng, J. D. Fryer, A. M. Fagan, and D. M. Holtzman. 2003. Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content. J. Biol. Chem. 278: 8043-8051. (Pubitemid 36800543)
40. Isaac, G., Z. Pernber, V. Gieselmann, E. Hansson, J. Bergquist, and J. E. Månsson. 2006. Sulfatide with short fatty acid dominates in astrocytes and neurons. FEBS J. 273: 1782-1790. (Pubitemid 43779830)
41. Schaeren-Wiemers, N., P. van der Bijl, and M. E. Schwab. 1995. The UDP-galactose:ceramide galactosyltransferase: expression pattern in oligodendrocytes and Schwann cells during myelination and substrate preference for hydroxyceramide. J. Neurochem. 65: 2267-2278.
42. Eckhardt, M., K. K. Hedayati, J. Pitsch, R. Lüllmann-Rauch, H. Beck, S. N. Fewou, and V. Gieselmann. 2007. Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy. J. Neurosci. 27: 9009-9021. (Pubitemid 47312065)
43. Han, X. 2007. Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomics. J. Neurochem. 103(Suppl.): 171-179.
44. van Zyl, R., V. Gieselmann, and M. Eckhardt. 2010. Elevated sulfatide levels in neurons cause lethal audiogenic seizures in mice. J. Neurochem. 112: 282-295.
45. Sabourdy, F., B. Kedjouar, S. C. Sorli, S. Colié, D. Milhas, Y. Salma, and T. Levade. 2008. Functions of sphingolipid metabolism in mammals-lessons from genetic defects. Biochim. Biophys. Acta. 1781: 145-183.
46. Cui, Y., B. Colsch, C. Afonso, N. Baumann, J. C. Tabet, J. M. Mallet, and Y. Zhang. 2008. Synthetic sulfogalactosylceramide (sulfatide) and its use for the mass spectrometric quantitative urinary determination in metachromatic leukodystrophies. Glycoconj. J. 25: 147-155. (Pubitemid 351238191)
47. Colsch, B., C. Afonso, J. C. Turpin, J. Portoukalian, J. C. Tabet, and N. Baumann. 2008. Sulfogalactosylceramides in motor and psycho-cognitive adult metachromatic leukodystrophy: relations between clinical, biochemical analysis and molecular aspects. Biochim. Biophys. Acta. 1780: 434-440. (Pubitemid 351395306)
48. Cheng, H., J. Xu, D. W. McKeel, Jr., and X. Han. 2003. Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study. Cell Mol. Biol. (Noisy-le-grand). 49: 809-818.
49. Fabelo, N., V. Martín, G. Santpere, R. Marín, L. Torrent, I. Ferrer, and M. Díaz. 2011. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. Mol. Med. 17: 1107-1118.
50. Han, X., D. M. Holtzman, D. W. McKeel, Jr., J. Kelley, and J. C. Morris. 2002. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J. Neurochem. 82: 809-818.
51. Liu, Q., J. Trotter, J. Zhang, M. M. Peters, H. Cheng, J. Bao, X. Han, E. J. Weeber, and G. Bu. 2010. Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. J. Neurosci. 30: 17068-17078.
52. Strittmatter, W. J., and A. D. Roses. 1996. Apolipoprotein E and Alzheimer's disease. Annu. Rev. Neurosci. 19: 53-77. (Pubitemid 26080822)
53. Hill, J. M., I. Steiner, K. E. Matthews, S. G. Trahan, T. P. Foster, and M. J. Ball. 2005. Statins lower the risk of developing Alzheimer's disease by limiting lipid raft endocytosis and decreasing the neuronal spread of Herpes simplex virus type 1. Med. Hypotheses. 64: 53-58. (Pubitemid 39469235)
54. Carter, C. J. 2008. Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades. Neurochem. Int. 52: 920-934.
55. Tadano-Aritomi, K., T. Hikita, H. Fujimoto, K. Suzuki, K. Motegi, and I. Ishizuka. 2000. Kidney lipids in galactosylceramide synthasedefi cient mice. Absence of galactosylsulfatide and compensatory increase in more polar sulfoglycolipids. J. Lipid Res. 41: 1237-1243. (Pubitemid 30666889)
56. Li, G., R. Hu, Y. Kamijo, T. Nakajima, T. Aoyama, T. Ehara, H. Shigematsu, R. Kannagi, M. Kyogashima, and A. Hara. 2009. Kidney dysfunction induced by protein overload nephropathy reduces serum sulfatide levels in mice. Nephrology (Carlton). 14: 658-662.
57. Zhang, X., T. Nakajima, Y. Kamijo, G. Li, R. Hu, R. Kannagi, M. Kyogashima, T. Aoyama, and A. Hara. 2009. Acute kidney injury induced by protein-overload nephropathy down-regulates gene expression of hepatic cerebroside sulfotransferase in mice, resulting in reduction of liver and serum sulfatides. Biochem. Biophys. Res. Commun. 390: 1382-1388.
58. Wang, L., Y. Kamijo, A. Matsumoto, T. Nakajima, M. Higuchi, R. Kannagi, M. Kyogashima, T. Aoyama, and A. Hara. 2011. Kidney transplantation recovers the reduction level of serum sulfatide in ESRD patients via processes correlated to oxidative stress and platelet count. Glycoconj. J. 28: 1 25 -1 35.
59. Shikata, K., Y. Suzuki, J. Wada, K. Hirata, M. Matsuda, H. Kawashima, T. Suzuki, M. Iizuka, H. Makino, and M. Miyasaka. 1999. L-selectin and its ligands mediate infiltration of mononuclear cells into kidney interstitium after ureteric obstruction. J. Pathol. 188: 93-99. (Pubitemid 29197321)
60. Ogawa, D., K. Shikata, K. Honke, S. Sato, M. Matsuda, R. Nagase, A. Tone, S. Okada, H. Usui, J. Wada, et al. 2004. Cerebroside sulfotransferase deficiency ameliorates L-selectin-dependent monocyte infiltration in the kidney after ureteral obstruction. J. Biol. Chem. 279: 2085-2090. (Pubitemid 38084481)
61. Lande, M. B., N. A. Priver, and M. L. Zeidel. 1994. Determinants of apical membrane permeabilities of barrier epithelia. Am. J. Physiol. 267: C367-C374.
62. Trick, D., J. Decker, H. J. Groene, M. Schulze, and H. Wiegandt. 1999. Regional expression of sulfatides in rat kidney: immunohistochemical staining by use of monospecific polyclonal antibodies. Histochem. Cell Biol. 111: 143-151. (Pubitemid 29148254)
63. Fredman, P., J. E. Mânsson, B. M. Rynmark, K. Josefsen, A. Ekblond, L. Halldner, T. Osterbye, T. Horn, and K. Buschard. 2000. The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling: possible involvement in insulin trafficking. Glycobiology. 10: 39-50. (Pubitemid 30122198)
64. Buschard, K., M. Blomqvist, J. E. Månsson, P. Fredman, L. Juhl, and J. Gromada. 2006. C16:0 sulfatide inhibits insulin secretion in rat β-cells by reducing the sensitivity of K ATP channels to ATP inhibition. Diabetes. 55: 2826-2834. (Pubitemid 44923683)
65. Blomqvist, M., T. Osterbye, J. E. Månsson, T. Horn, K. Buschard, and P. Fredman. 2003. Selective lack of the C16:0 fatty acid isoform of sulfatide in pancreas of type II diabetic animal models. APMIS. 111: 867-877. (Pubitemid 37222731)
66. Buschard, K., M. Høy, K. Bokvist, H. L. Olsen, S. Madsbad, P. Fredman, and J. Gromada. 2002. Sulfatide controls insulin secretion by modulation of ATP-sensitive K(+)-channel activity and Ca(2+)-dependent exocytosis in rat pancreatic beta-cells. Diabetes. 51: 2514-2521. (Pubitemid 34827401)
67. Osterbye, T., K. H. Jorgensen, P. Fredman, J. Tranum-Jensen, A. Kaas, J. Brange, J. L. Whittingham, and K. Buschard. 2001. Sulfatide promotes the folding of proinsulin, preserves insulin crystals, and mediates its monomerization. Glycobiology. 11: 473-479. (Pubitemid 32655241)
68. Andersson, K., K. Buschard, P. Fredman, A. Kaas, A. M. Lidström, S. Madsbad, H. Mortensen, and M. Jan-Eric. 2002. Patients with insulin-dependent diabetes but not those with non-insulin-dependent diabetes have anti-sulfatide antibodies as determined with a new ELISA assay. Autoimmunity. 35: 463-468. (Pubitemid 36040381)
69. Buschard, K., K. Hanspers, P. Fredman, and E. P. Reich. 2001. Treatment with sulfatide or its precursor, galactosylceramide, prevents diabetes in NOD mice. Autoimmunity. 34: 9-17. (Pubitemid 32888271)
70. Buschard, K., M. Diamant, L. E. Bovin, J. E. Mansson, P. Fredman, and K. Bendtzen. 1996. Sulphatide and its precursor galactosylceramide influence the production of cytokines in human mononuclear cells. APMIS. 104: 938-944. (Pubitemid 27064743)
71. Bovin, L. F., P. Fredman, J. E. Månsson, K. Buschard, and K. Bendtzen. 1999. In vitro production of cytokines is influenced by sulfatide and its precursor galactosylceramide. FEBS Lett. 455: 339-343. (Pubitemid 29333063)
72. Roeske-Nielsen, A., P. Fredman, J. E. Mansson, K. Bendtzen, and K. Buschard. 2004. Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells. Immunol. Lett. 91: 205-211. (Pubitemid 38296380)
73. Suzuki, Y., Y. Toda, T. Tamatani, T. Watanabe, T. Suzuki, T. Nakao, K. Murase, M. Kiso, A. Hasegawa, K. Tadano-Aritomi, et al. 1993. Sulfated glycolipids are ligands for a lymphocyte homing receptor, L-selectin (LECAM-1), binding epitope in sulfated sugar chain. Biochem. Biophys. Res. Commun. 190: 426-434. (Pubitemid 23209628)
74. Yang, X. D., N. Karin, R. Tisch, L. Steinman, and H. O. McDevitt. 1993. Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors. Proc. Natl. Acad. Sci. USA. 90: 10494-10498. (Pubitemid 23347068)
75. Roeske-Nielsen, A., L. T. Dalgaard, J. E. Månsson, and K. Buschard. 2010. The glycolipid sulfatide protects insulin-producing cells against cytokine-induced apoptosis, a possible role in diabetes. Diabetes Metab. Res. Rev. 26: 631-638.
76. Miyazaki, Y., R. Pipek, L. J. Mandarino, and R. A. DeFronzo. 2003. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Int. J. Obes. Relat. Metab. Disord. 27: 88-94. (Pubitemid 36152785)
77. Buschard, K., P. Fredman, E. Bog-Hansen, M. Blomqvist, J. Hedner, L. Rastam, and U. Lindblad. 2005. Low serum concentration of sulfatide and presence of sulfated lactosylceramid are associated with Type 2 diabetes. The Skaraborg Project. Diabet. Med. 22: 1190-1198. (Pubitemid 41224179)
78. Roeske-Nielsen, A., K. Buschard, J. E. Manson, L. Rastam, and U. Lindblad. 2009. A variation in the cerebroside sulfotransferase gene is linked to exercise-modified insulin resistance and to type 2 diabetes. Exp. Diabetes Res. 2009: 429593.
79. Shamshiev, A., H. J. Gober, A. Donda, Z. Mazorra, L. Mori, and G. De Libero. 2002. Presentation of the same glycolipid by different CD1 molecules. J. Exp. Med. 195: 1013-1021. (Pubitemid 34412003)
80. Cernadas, M., M. Cavallari, G. Watts, L. Mori, G. De Libero, and M. B. Brenner. 2010. Early recycling compartment trafficking of CD1a is essential for its intersection and presentation of lipid antigens. J. Immunol. 184: 1235-1241.
81. Blomqvist, M., S. Rhost, S. Teneberg, L. Löfbom, T. Osterbye, M. Brigl, J. E. Månsson, and S. L. Cardell. 2009. Multiple tissues-pecific isoforms of sulfatide activate CD1d-restricted type II NKT cells. Eur. J. Immunol. 39: 1726-1735.
82. Arrenberg, P., R. Halder, Y. Dai, I. Maricic, and V. Kumar. 2010. Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid. Proc. Natl. Acad. Sci. USA. 107: 10984-10989.
83. Arrenberg, P., R. Halder, and V. Kumar. 2009. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens. J. Cell. Physiol. 218: 246-250.
84. Halder, R. C., A. Jahng, I. Maricic, and V. Kumar. 2007. Mini review: immune response to myelin-derived sulfatide and CNS-demyelination. Neurochem. Res. 32: 257-262. (Pubitemid 46238871)
85. Arrenberg, P., I. Maricic, and V. Kumar. 2011. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice. Gastroenterology. 140: 646-655.
86. Yang, S. H., J. P. Lee, H. R. Jang, R. H. Cha, S. S. Han, U. S. Jeon, D. K. Kim, J. Song, D. S. Lee, and Y. S. Kim. 2011. Sulfatide-reactive natural killer T cells abrogate ischemia-reperfusion injury. J. Am. Soc. Nephrol. 22: 1305-1314.
87. Tam, F. W. 2002. Role of selectins in glomerulonephritis. Clin. Exp. Immunol. 129: 1-3.
88. Garcia, J., N. Callewaert, and L. Borsig. 2007. P-selectin mediates metastatic progression through binding to sulfatides on tumor cells. Glycobiology. 17: 185-196. (Pubitemid 46152535)
89. Simonis, D., M. Schlesinger, C. Seelandt, L. Borsig, and G. Bendas. 2010. Analysis of SM4 sulfatide as a P-selectin ligand using model membranes. Biophys. Chem. 150: 98-104.
90. Duchesneau, P., E. Gallagher, B. Walcheck, and T. K. Waddell. 2007. Up-regulation of leukocyte CXCR4 expression by sulfatide: an L-selectin-dependent pathway on CD4 + T cells. Eur. J. Immunol. 37: 2949-2960. (Pubitemid 47578313)
91. Sandhoff, R., H. Grieshaber, R. Djafarzadeh, T. P. Sijmonsma, A. E. Proudfoot, T. M. Handel, H. Wiegandt, P. J. Nelson, and H. J. Gröne. 2005. Chemokines bind to sulfatides as revealed by surface plasmon resonance. Biochim. Biophys. Acta. 1687: 52-63. (Pubitemid 40228985)
92. Popovic, Z. V., R. Sandhoff, T. P. Sijmonsma, S. Kaden, R. Jennemann, E. Kiss, E. Tone, F. Autschbach, N. Platt, E. Malle, et al. 2007. Sulfated glycosphingolipid as mediator of phagocytosis: SM4s enhances apoptotic cell clearance and modulates macrophage activity. J. Immunol. 179: 6770-6782.
93. Altomare, E., S. Fallarini, C. O. Battaglini, M. Mossotti, L. Panza, and G. Lombardi. 2011. Synthetic isoforms of endogenous sulfatides differently modulate indoleamine 2,3-dioxygenase in antigen presenting cells. Life Sci. 89: 176-181.
94. Kyogashima, M., T. Sakai, J. Onaya, and A. Hara. 2001. Roles of galactose and sulfate residues in sulfatides for their antagonistic functions in the blood coagulation system. Glycoconj. J. 18: 245-251. (Pubitemid 33081992)
95. Ida, M., A. Satoh, I. Matsumoto, and K. Kojima-Aikawa. 2004. Human annexin V binds to sulfatide: contribution to regulation of blood coagulation. J. Biochem. 135: 583-588. (Pubitemid 38855950)
96. Merten, M., and P. Thiagarajan. 2001. Role for sulfatides in platelet aggregation. Circulation. 104: 2955-2960. (Pubitemid 33139109)
97. Merten, M., and P. Thiagarajan. 2004. P-selectin in arterial thrombosis. Z. Kardiol. 93: 855-863. (Pubitemid 40064238)
98. Hu, R., G. Li, Y. Kamijo, T. Aoyama, T. Nakajima, T. Inoue, K. Node, R. Kannagi, M. Kyogashima, and A. Hara. 2007. Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure. Glycoconj. J. 24: 565-571. (Pubitemid 350029463)
99. Drahos, K. E., J. D. Welsh, C. V. Finkielstein, and D. G. Capelluto. 2009. Sulfatides partition disabled-2 in response to platelet activation. PLoS ONE. 4: e8007.
100. Welsh, J. D., J. J. Charonko, A. Salmanzadeh, K. E. Drahos, H. Shafiee, M. A. Stremler, R. V. Davalos, D. G. Capelluto, P. P. Vlachos, and C. V. Finkielstein. 2011. Disabled-2 modulates homotypic and heterotypic platelet interactions by binding to sulfatides. Br. J. Haematol. 154: 122-133.
101. Osawa, H., K. Sugano, T. Igari, T. Tai, M. Iwamori, and M. Kawakami. 1997. Immunohistochemical study of sulfatide expression in gastric carcinoma: alteration of sulfatide expression. J. Clin. Gastroenterol. 25 (Suppl.): 135-140.
102. Kobayashi, T., K. Honke, I. Tsunematsu, H. Kagaya, S. Nishikawa, K. Hokari, M. Kato, H. Takeda, T. Sugiyama, A. Higuchi, et al. 1999. Detection of cerebroside sulfotransferase mRNA in human gastric mucosa and adenocarcinoma. Cancer Lett. 138: 45-51. (Pubitemid 29189183)
103. Gasa, S., M. T. Casl, T. Jin, K. Kamio, Y. Uehara, T. Miyazaki, and A. Makita. 1991. Elevated serum level of glycolipid sulfotransferase in patients with hepatocellular carcinoma. Cancer Lett. 59: 19-24.
104. Kamio, K., T. Jin, S. Gasa, M. Ohhira, K. Honke, N. Kasai, and A. Makita. 1992. Inconsistent expression of glycolipid sulfotransferase activity between hepatoma and serum. Tohoku J. Exp. Med. 168: 29-35.
105. Honke, K., M. Tsuda, Y. Hirahara, N. Miyao, T. Tsukamoto, M. Satoh, and Y. Wada. 1998. Cancer-associated expression of glycolipid sulfotransferase gene in human renal cell carcinoma cells. Cancer Res. 58: 3800-3805. (Pubitemid 28405633)
106. Sakakibara, N., S. Gasa, K. Kamio, A. Makita, K. Nonomura, M. Togashi, T. Koyanagi, Y. Hatae, and K. Takeda. 1991. Distinctive glycolipid patterns in Wilms' tumor and renal cell carcinoma. Cancer Lett. 57: 187-192.
107. Balbaa, M., K. Honke, and A. Makita. 1996. Regulation of glycolipid sulfotransferase by tyrosine kinases in human renal cancer cells. Biochim. Biophys. Acta. 1299: 141-145. (Pubitemid 26007742)
108. Yabunaka, N., K. Honke, A. Ishii, Y. Ogiso, N. Kuzumaki, Y. Agishi, and A. Makita. 1997. Involvement of Ras in the expression of glycolipid sulfotransferase in human renal cancer cells. Int. J. Cancer. 71: 620-623. (Pubitemid 27239373)
109. Kobayashi, T., K. Honke, S. Gasa, N. Kato, T. Miyazaki, and A. Makita. 1993. Epidermal growth factor elevates the activity levels of glycolipid sulfotransferases in renal-cell-carcinoma cells. Int. J. Cancer. 55: 448-452. (Pubitemid 23300597)
110. Kobayashi, T., K. Honke, S. Gasa, T. Miyazaki, H. Tajima, K. Matsumoto, T. Nakamura, and A. Makita. 1994. Hepatocyte growth factor elevates the activity levels of glycolipid sulfotransferases in renal cell carcinoma cells. Eur. J. Biochem. 219: 407-413. (Pubitemid 24053656)
111. Abul-Milh, M., S. E. Paradis, J. D. Dubreuil, and M. Jacques. 1999. Binding of Actinobacillus pleuropneumoniae lipopolysaccharides to glycosphingolipids evaluated by thin-layer chromatography. Infect. Immun. 67: 4983-4987. (Pubitemid 29455263)
112. Brennan, M. J., J. H. Hannah, and E. Leininger. 1991. Adhesion of Bordetella pertussis to sulfatides and to the GalNAc beta 4Gal sequence found in glycosphingolipids. J. Biol. Chem. 266: 18827-18831. (Pubitemid 21908158)
113. Piao, H., M. Minohara, N. Kawamura, W. Li, Y. Mizunoe, F. Umehara, Y. Goto, S. Kusunoki, T. Matsushita, K. Ikenaka, et al. 2010. Induction of paranodal myelin detachment and sodium channel loss in vivo by Campylobacter jejuni DNA-binding protein from starved cells (C-Dps) in myelinated nerve fibers. J. Neurol. Sci. 288: 54-62.
114. Piao, H., M. Minohara, N. Kawamura, W. Li, T. Matsushita, R. Yamasaki, Y. Mizunoe, and J. Kira. 2011. Tissue binding patterns and in vitro effects of Campylobacter jejuni DNA-binding protein from starved cells. Neurochem. Res. 36: 58-66.
115. Zhu, G., H. Chen, B. K. Choi, F. Del Piero, and D. M. Schifferli. 2005. Histone H1 proteins act as receptors for the 987P fimbriae of enterotoxigenic Escherichia coli. J. Biol. Chem. 280: 23057-23065. (Pubitemid 40853216)
116. Jansson, L., J. Tobias, C. Jarefjäll, M. Lebens, A. M. Svennerholm, and S. Teneberg. 2009. Sulfatide recognition by colonization factor antigen CS6 from enterotoxigenic Escherichia coli. PLoS ONE. 4: e4487.
117. Pantzar, M., S. Teneberg, and T. Lagergård. 2006. Binding of Haemophilus ducreyi to carbohydrate receptors is mediated by the 58.5-kDa GroEL heat shock protein. Microbes Infect. 8: 2452-2458. (Pubitemid 44499046)
118. Hartmann, E., C. A. Lingwood, and J. Reidl. 2001. Heat-inducible surface stress protein (Hsp70) mediates sulfatide recognition of the respiratory pathogen Haemophilus influenzae. Infect. Immun. 69: 3438-3441. (Pubitemid 32332246)
119. Kamisago, S., M. Iwamori, T. Tai, K. Mitamura, Y. Yazaki, and K. Sugano. 1996. Role of sulfatides in adhesion of Helicobacter pylori to gastric cancer cells. Infect. Immun. 64: 624-628.
120. Mukai, T., T. Asasaka, E. Sato, K. Mori, M. Matsumoto, and H. Ohori. 2002. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol. Med. Microbiol. 32: 105-110. (Pubitemid 34124108)
121. Ozcelik, P., F. B. Bezirci, Y. Suzuki, H. Uzawa, Y. Nishida, K. Kobayashi, T. Suzuki, D. Miyamoto, T. Nagatake, and K. Ahmed. 2006. Sulfatide and its synthetic analogues recognition by Moraxella catarrhalis. Microbiol. Immunol. 50: 967-970. (Pubitemid 44974652)
122. Olson, L. D., and A. A. Gilbert. 1993. Characteristics of Mycoplasma hominis adhesion. J. Bacteriol. 175: 3224-3227. (Pubitemid 23148764)
123. Zhang, Q., T. F. Young, and R. F. Ross. 1994. Glycolipid receptors for attachment of Mycoplasma hyopneumoniae to porcine respiratory ciliated cells. Infect. Immun. 62: 4367-4373. (Pubitemid 24301965)
124. Krivan, H. C., L. D. Olson, M. F. Barile, V. Ginsburg, and D. D. Roberts. 1989. Adhesion of Mycoplasma pneumoniae to sulfated glycolipids and inhibition by dextran sulfate. J. Biol. Chem. 264: 9283-9288. (Pubitemid 19157565)
125. Yagci, A., T. Yagci, B. Sener, Y. Suziki, and K. Ahmed. 2007. Sulfatide mediates attachment of Pseudomonas aeruginosa to human pharyngeal epithelial cells. New Microbiol. 30: 167-171. (Pubitemid 46984124)
126. Kaneda, K., T. Masuzawa, K. Yasugami, T. Suzuki, Y. Suzuki, and Y. Yanagihara. 1997. Glycosphingolipid-binding protein of Borrelia burgdorferi sensu lato. Infect. Immun. 65: 3180-3185. (Pubitemid 27342396)
127. Mamelak, D., M. Mylvaganam, H. Whetstone, E. Hartmann, W. Lennarz, P. B. Wyrick, J. Raulston, H. Han, P. Hoffman, and C. A. Lingwood. 2001. Hsp70s contain a specific sulfogalactolipid binding site. Differential aglycone influence on sulfogalactosyl ceramide binding by recombinant prokaryotic and eukaryotic hsp70 family members. Biochemistry. 40: 3572-3582. (Pubitemid 32242814)
128. Xia, B., G. P. Sachdev, and R. D. Cummings. 2007. Pseudomonas aeruginosa mucoid strain 8830 binds glycans containing the sialyl- Lewis x epitope. Glycoconj. J. 24: 87-95. (Pubitemid 44935068)
129. Blomqvist, M., T. Osterbye, J. E. Månsson, K. Buschard, and P. Fredman. 2006. Uptake of the glycosphingolipid sulfatide in the gastrointestinal tract and pancreas in vivo and in isolated islets of Langerhans. Lipids Health Dis. 5: 26.
130. Huesca, M., S. Borgia, P. Hoffman, and C. A. Lingwood. 1996. Acidic pH changes receptor binding specificity of Helicobacter pylori : a binary adhesion model in which surface heat shock (stress) proteins mediate sulfatide recognition in gastric colonization. Infect. Immun. 64: 2643-2648. (Pubitemid 26226828)
131. 3-GalCer in human cervical epithelia and uterine endometria, and follicular phase-characteristic formation of a gangliosidederived negative charge gradient in different regions of fallopian tubes. Biochim. Biophys. Acta. 1170: 232-236.
132. Pancake, S. J., G. D. Holt, S. Mellouk, and S. L. Hoffman. 1992. Malaria sporozoites and circumsporozoite proteins bind specifically to sulfated glycoconjugates. J. Cell Biol. 117: 1351-1357.
133. Toda, G., Y. Ikeda, M. Kashiwagi, M. Iwamori, and H. Oka. 1990. Hepatocyte plasma membrane glycosphingolipid reactive with sera from patients with autoimmune chronic active hepatitis: its identification as sulfatide. Hepatology. 12: 664-670. (Pubitemid 20349248)
134. Rousset, E., J. Harel, and J. D. Dubreuil. 1998. Sulfatide from the pig jejunum brush border epithelial cell surface is involved in binding of Escherichia coli enterotoxin b. Infect. Immun. 66: 5650-5658. (Pubitemid 28531818)
135. Beausoleil, H. E., and J. D. Dubreuil. 2001. In vitro binding characteristics and affinity for sulfatide of Escherichia coli STb enterotoxin. Receptors Channels. 7: 401-411.
136. Bianco, I. D., G. D. Fidelio, and B. Maggio. 1990. Effect of sulfatide and gangliosides on phospholipase C and phospholipase A2 activity. A monolayer study. Biochim. Biophys. Acta. 1026: 179-185. (Pubitemid 20230023)
137. Rivera-Marrero, C. A., J. D. Ritzenthaler, S. A. Newburn, J. Roman, and R. D. Cummings. 2002. Molecular cloning and expression of a novel glycolipid sulfotransferase in Mycobacterium tuberculosis. Microbiology. 148: 783-792. (Pubitemid 34232862)
138. Miyazaki, Y., S. Oka, S. Yamaguchi, S. Mizuno, and I. Yano. 1995. Stimulation of phagocytosis and phagosome-lysosome fusion by glycosphingolipids from Sphingomonas paucimobilis. J. Biochem. 118: 271-277.
139. Delézay, O., D. Hammache, J. Fantini, and N. Yahi. 1996. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. Biochemistry. 35: 15663-15671. (Pubitemid 26422303)
140. Cook, D. G., J. Fantini, S. L. Spitalnik, and F. Gonzalez-Scarano. 1994. Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop. Virology. 201: 206-214. (Pubitemid 24187267)
141. Laudanna, C., G. Constantin, P. Baron, E. Scarpini, G. Scarlato, G. Cabrini, C. Dechecchi, F. Rossi, M. A. Cassatella, and G. Berton. 1994. Sulfatides trigger increase of cytosolic free calcium and enhanced expression of tumor necrosis factor-alpha and interleukin-8 mRNA in human neutrophils. Evidence for a role of L-selectin as a signaling molecule. J. Biol. Chem. 269: 4021-4026.
142. Schneider-Schaulies, J., S. Schneider-Schaulies, R. Brinkmann, P. Tas, M. Halbrugge, U. Walter, H. C. Holmes, and V. Ter Meulen. 1992. HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase. Virology. 191: 765-772. (Pubitemid 23022481)
143. Seddiki, N., A. Ramdani, L. Saffar, J. Portoukalian, J. C. Gluckman, and L. Gattegno. 1994. A monoclonal antibody directed to sulfatide inhibits the binding of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein to macrophages but not their infection by the virus. Biochim. Biophys. Acta. 1225: 289-296. (Pubitemid 24066580)
144. Delézay, O., N. Koch, N. Yahi, D. Hammache, C. Tourres, C. Tamalet, and J. Fantini. 1997. Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29. AIDS. 11: 1311-1318. (Pubitemid 27423290)
145. Harouse, J. M., S. Bhat, S. L. Spitalnik, M. Laughlin, K. Stefano, D. H. Silberberg, and F. Gonzalez-Scarano. 1991. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science. 253: 320-323. (Pubitemid 21917158)
146. Kensinger, R. D., B. J. Catalone, F. C. Krebs, B. Wigdahl, and C. L. Schengrund. 2004. Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection. Antimicrob. Agents Chemother. 48: 1614-1623. (Pubitemid 38544366)
147. +cells. Virology. 246: 211-220.
148. Harouse, J. M., R. G. Collman, and F. González-Scarano. 1995. Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3′-sulfo- galactosyl ceramide-positive cell line. J. Virol. 69: 7383-7390.
149. Albright, A. V., J. Strizki, J. M. Harouse, E. Lavi, M. O'Connor, and F. González-Scarano. 1996. HIV-1 infection of cultured human adult oligodendrocytes. Virology. 217: 211-219. (Pubitemid 26103610)
150. Gisslén, M., P. Fredman, G. Norkrans, and L. Hagberg. 1996. Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I infection. AIDS Res. Hum. Retroviruses. 12: 149-155. (Pubitemid 26039714)
151. Gisslén, M., A. Lekman, and P. Fredman. 1999. High levels in serum, but no signs of intrathecal synthesis of anti-sulfatide antibodies in HIV-1 infected individuals with or without central nervous system complications. J. Neuroimmunol. 94: 153-156. (Pubitemid 29071255)
152. Souayah, N., N. F. Mian, Y. Gu, and A. A. Ilyas. 2007. Elevated antisulfatide antibodies in Guillain-Barré syndrome in T cell depleted at end-stage AIDS. J. Neuroimmunol. 188: 143-145. (Pubitemid 47095023)
153. Sundell, I. B., R. Halder, M. Zhang, I. Maricic, P. S. Koka, and V. Kumar. 2010. Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoeisis. J. Stem Cells. 5: 33-42.
154. Alpa, M., B. Ferrero, R. Cavallo, C. Naretto, E. Menegatti, D. Di Simone, F. Napoli, R. La Grotta, D. Rossi, S. Baldovino, et al. 2008. Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia. Autoimmun. Rev. 8: 56-58.
155. Sakamoto, H., K. Okamoto, M. Aoki, H. Kato, A. Katsume, A. Ohta, T. Tsukuda, N. Shimma, Y. Aoki, M. Arisawa, et al. 2005. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy. Nat. Chem. Biol. 1: 333-337.
156. Suzuki, T., A. Sometani, Y. Yamazaki, G. Horiike, Y. Mizutani, H. Masuda, M. Yamada, H. Tahara, G. Xu, D. Miyamoto, et al. 1996. Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection. Biochem. J. 318: 389-393. (Pubitemid 26305935)
157. Suzuki, T., T. Takahashi, D. Nishinaka, M. Murakami, S. Fujii, K. I. Hidari, D. Miyamoto, Y. T. Li, and Y. Suzuki. 2003. Inhibition of influenza A virus sialidase activity by sulfatide. FEBS Lett. 553: 355-359. (Pubitemid 37315630)
158. Takahashi, T., K. Murakami, M. Nagakura, H. Kishita, S. Watanabe, K. Honke, K. Ogura, T. Tai, K. Kawasaki, D. Miyamoto, et al. 2008. Sulfatide is required for efficient replication of influenza A virus. J. Virol. 82: 5940-5950. (Pubitemid 351822267)
159. Ogura, K., K. Kohno, and T. Tai. 1998. Molecular cloning of a rat brain cDNA, with homology to a tyrosine kinase substrate, that induces galactosylceramide expression in COS-7 cells. J. Neurochem. 71: 1827-1836. (Pubitemid 28491537)
160. Takahashi, T., H. Satoh, M. Takaguchi, S. Takafuji, H. Yokoyama, S. Fujii, and T. Suzuki. 2010. Binding of sulfatide to recombinant hemagglutinin of influenza A virus produced by a baculovirus protein expression system. J. Biochem. 147: 459-462.
161. Perino, J., C. H. Foo, D. Spehner, G. H. Cohen, R. J. Eisenberg, J. M. Crance, and A. L. Favier. 2011. Role of sulfatide in vaccinia virus infection. Biol. Cell. 103: 319-331